Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Business

CVS Health to pull decongestants with phenylephrine off shelves

by October 20, 2023
October 20, 2023
CVS Health to pull decongestants with phenylephrine off shelves

U.S. pharmacy chain CVS Health said on Thursday it is pulling some of the most common decongestants with phenylephrine as the only active ingredient from its shelves and will no longer sell them.

The move comes after a panel of advisers to U.S. health regulators raised doubts over the efficacy of the ingredient.

Last month, the panel refused to back the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, adding that no more trials were required to prove otherwise.

CVS said “other oral cough and cold products will continue to be offered to meet consumer needs.”

Phenylephrine was substituted for pseudoephedrine in many non-prescription cold and allergy medicines after the latter was restricted amid reports of abuse.

Phenylephrine is a major component used in some of popular products like Benadryl, Sudafed, GSK’s Advil and Kenvue’s Tylenol.

This post appeared first on NBC NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Tesla Stock Has High Expectations: A Strong Pop or Plunge
next post
World’s Largest Miners Confirmed For This Year’s Resourcing Tomorrow Event

Related Posts

Microsoft to cut 3% of its workforce

May 14, 2025

U.S. foreign tax bill sends jitters across Wall...

May 31, 2025

Tesla investors want Elon Musk to answer questions...

January 30, 2025

Amazon surpasses Walmart in revenue for the first...

February 22, 2025

The U.S. added 216,000 jobs in December, much...

January 7, 2024

Cyberattack cost MGM Resorts about $100 million, Las...

October 9, 2023

Here’s how the Houthi attacks in the Red...

December 19, 2023

Rivian secures up to $5 billion from Volkswagen;...

June 27, 2024

Ben & Jerry’s co-founder resigns, claiming parent company...

September 26, 2025

U.S. passport processing times return to pre-pandemic levels

December 20, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • Vince Lanci: Silver’s London Liquidity Crisis — What’s Happening, What’s Next

    • Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

    • Top 5 Canadian Mining Stocks This Week: JZR Gold Jumps 113 Percent

    • Tech Weekly: Broadcom and OpenAI Sign Deal, AMD and Oracle Announce Partnership

    • Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units

    Categories

    • Business (1,400)
    • Investing (3,043)
    • Politics (3,699)
    • Stocks (1,823)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved